US Patent 9616107 Therapy for kidney disease and/or heart failure
Patent 9616107 was granted and assigned to Capricor Therapeutics, Inc. on April, 2017 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9616107 Therapy for kidney disease and/or heart failure
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
